Medical and Pharmaceutical Freenome gets FDA breakthrough designation for ‘SimpleScreen’ lung cancer blood test Achievement builds on firm securing agency's approval for a colorectal cancer test variation Rowan DunneAugust 13, 2026
Mining United States Antimony drops 25% on revenue slump, slashed guidance Results are significantly linked to antimony's decline in value throughout H1 Rowan DunneAugust 13, 2026
Cannabis Aurora sees 22% surge on hostile takeover bid from Curaleaf If successful, the combined firm would be worth about US$3 billion Rowan DunneAugust 12, 2026
Silver CME Group to trade silver futures 24/7 next month This decision follow's the firm's success with gold futures Rowan DunneAugust 12, 2026
Mining Blue Moon Metals expands U.S. mining footprint with 33 tungsten, antimony projects This is the first time Blue Moon has pursued antimony Rowan DunneAugust 11, 2026
Medical and Pharmaceutical Sionna shares plummet after cystic fibrosis clinical trial failure The 92% plunge has been beneficial for competitor Vertex Pharma Rowan DunneAugust 11, 2026
Stock News Humanoid robot demand makes Unitree’s IPO 8,000 times oversubscribed The leading firm is expecting to raise US$900M from its long-awaited public launch Rowan DunneAugust 10, 2026
Medical and Pharmaceutical Manitoba Lung Association and BioMark use blood biopsy to tackle radon threat They are organising a feasibility study assessing the efficacy of BioMark's blood test on those exposed to the gas Rowan DunneAugust 9, 2026
Gold VanEck gold mining ETFs soar alongside major producers Silver and silver ETFs also saw considerable gains last week Rowan DunneAugust 9, 2026
Mining Perpetua, U.S. Army and Idaho National Lab celebrate antimony plant’s launch Reducing critical mineral processing reliance on China is the aim of the game Rowan DunneJuly 30, 2026